Drug Shortage Report for NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
| Report ID | 76025 |
| Drug Identification Number | 02443295 |
| Brand name | NXSTAGE PUREFLOW SOLUTION RFP-209-CAN |
| Common or Proper name | Hemodialysis Solution |
| Company Name | NXSTAGE MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE |
| Strength(s) | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G |
| Dosage form(s) | SOLUTION |
| Route of administration | DIALYSIS |
| Packaging size | 5 L |
| ATC code | B05Z |
| ATC description | HEMODIALYTICS AND HEMOFILTRATES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-02-11 |
| Estimated end date | Unknown |
| Actual end date | 2019-03-11 |
| Shortage status | Resolved |
| Updated date | 2019-03-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 350 MERRIMACK STREET LAWRENCE, MASSACHUSETTS UNITED STATES 01843 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2019-03-12 | English | Compare |
| v9 | 2019-03-11 | French | Compare |
| v8 | 2019-03-11 | English | Compare |
| v7 | 2019-03-11 | English | Compare |
| v6 | 2019-03-11 | English | Compare |
| v5 | 2019-02-15 | French | Compare |
| v4 | 2019-02-15 | English | Compare |
| v3 | 2019-02-15 | French | Compare |
| v2 | 2019-02-15 | English | Compare |
| v1 | 2019-02-15 | English | Compare |
Showing 1 to 10 of 10